Afs Financial Group, LLC Pfizer Inc Transaction History

Afs Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $511,834 - $664,816	-19,588 Reduced 47.88%	21,320 $614 Million
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $60,104 - $70,256	-1,873 Reduced 4.38%	40,908 $1.36 Billion
Q2 2023 Jul 17, 2023	BUY	$36.12 - $41.79 $99,655 - $115,298	2,759 Added 6.89%	42,781 $1.57 Billion
Q1 2023 Apr 20, 2023	BUY	$39.39 - $51.28 $27,336 - $35,588	694 Added 1.76%	40,022 $1.63 Billion
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $1.64 Million - $2.14 Million	39,328 New	39,328 $2.02 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Afs Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Afs Financial Group, LLC with notifications on news.